UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The Synthesis of Imidazo[1,2-a]pyrazines as Inhibitors of the VirB11 ATPase and their Incorporation into Bivalent Compounds

Sayer, JR; (2013) The Synthesis of Imidazo[1,2-a]pyrazines as Inhibitors of the VirB11 ATPase and their Incorporation into Bivalent Compounds. Doctoral thesis (PhD), UCL (University College London). Green open access

[thumbnail of James Sayer Thesis.pdf]
Preview
Text
James Sayer Thesis.pdf

Download (11MB) | Preview

Abstract

Helicobacter pylori are gram negative bacteria that colonise in the human stomach causing illnesses such as peptide ulcers and various cancers. Through targeting a component of their secretion apparatus, it is envisaged that translocation of toxic molecules will be inhibited and therefore virulence would be reduced. Virtual high throughput screening of the Helicobacter pylori VirB11 ATPase, HP0525, identified imidazo[1,2-a]pyrazine compounds as potential ATP mimics and ATPase inhibitors. Synthesis of these target compounds was carried out, with two routes established to deliver 2- and 3- aryl regioisomers. In vitro screening identified compound 14 as the lead compound (IC50 = 7 μM) and studies have shown it to be a competitive inhibitor of ATP. Based upon in silico interactions of this compound within the ATP binding site, a second generation of compounds were then designed and synthesised. Whilst these compounds showed no major improvements in potency, two further inhibitors were identified as potential leads. Trends in the structure-activity-relationship of these imidazo[1,2- a]pyrazine compounds have also been identified, paving the way for the design of further novel compounds. In addition, the lead compound 14 was successfully incorporated into peptide-small molecule bivalent compounds. The objective of the peptide moiety was to disrupt hexamer formation of the VirB11 ATPase, whilst the small molecule targets the enzyme active site. Initial studies have shown this class of bivalent compound not to inhibit below 500 μM. Further investigation of these bivalent compounds will be required. Presented in this thesis are details of the synthesis, biological testing and computational evaluation of imidazo[1,2-a]pyrazines and their incorporation into the synthesis of bivalent compounds.

Type: Thesis (Doctoral)
Qualification: PhD
Title: The Synthesis of Imidazo[1,2-a]pyrazines as Inhibitors of the VirB11 ATPase and their Incorporation into Bivalent Compounds
Open access status: An open access version is available from UCL Discovery
Language: English
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry
URI: https://discovery.ucl.ac.uk/id/eprint/1398301
Downloads since deposit
375Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item